Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

Full Year 2024 Results Key Financial Results Revenue: US$42.9b (flat on FY ...

X-Elio will supply 245GWh of clean energy annually to four pharmaceutical companies through its Lorca Solar project.

ELIO, Thermo Fisher Scientific is closer to its goal of powering its European sites with 100% renewable energy ...

This marks the second round of layoffs at the company in less than three months. In November, the company cut 160 jobs across several Massachusetts sites, including the closure of its Lexington ...

Thermo Fisher Scientific Inc. announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Registry.